IOVANCE BIOTHERAPEUTICS, INC. Retained Earnings
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Retained Earnings of -$2.90 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$2.90B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$2.85B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$2.78B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$2.70B.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$2.90B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$2.85B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | -$2.78B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$2.70B 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$2.61B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$2.50B 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$2.38B 10-K · filed 2026-02-24 | |
| 2024-09-30 | -$2.31B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$2.22B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$2.13B 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$2.01B 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$1.90B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | -$1.78B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | -$1.68B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$1.57B 10-K · filed 2024-02-28 | |
| 2022-09-30 | -$1.46B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | -$1.36B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$1.26B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | -$1.17B 10-K · filed 2023-02-28 | |
| 2021-09-30 | -$1.07B 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$986.99M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$905.64M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$830.19M 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$761.80M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$703.23M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$640.21M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | -$570.61M 10-K · filed 2021-02-25 | |
| 2019-09-30 | -$507.04M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | -$457.56M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | -$410.01M 10-Q · filed 2019-05-07 | |
| 2019-01-01 | $300.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | -$372.76M 10-K · filed 2020-02-25 | |
| 2018-09-30 | -$340.19M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | -$306.36M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | -$275.69M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$249.18M 10-K · filed 2019-02-28 | |
| 2017-09-30 | -$223.33M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | -$201.18M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | -$177.80M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | -$157.12M 10-K · filed 2018-03-12 | |
| 2016-09-30 | -$141.43M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | -$122.67M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$111.11M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | -$104.22M 10-K · filed 2017-03-09 | |
| 2015-09-30 | -$95.84M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | -$88.23M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$81.86M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$76.56M 10-K · filed 2016-03-11 | -$76.56M 10-K · filed 2015-03-16 |
| 2014-09-30 | -$71.70M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$68.90M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | -$66.79M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | -$64.53M 10-K · filed 2015-03-16 | |
| 2013-09-30 | -$44.57M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$35.16M 10-Q · filed 2013-10-23 | |
| 2013-03-31 | -$31.73M 10-Q · filed 2013-10-23 | |
| 2012-12-31 | -$30.68M 10-K · filed 2014-03-28 | |
| 2012-09-30 | -$34.15M 10-Q · filed 2013-01-25 | |
| 2012-06-30 | -$33.48M 10-Q/A · filed 2012-09-10 | |
| 2012-03-31 | -$33.15M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$27.38M 10-K · filed 2013-09-23 | |
| 2011-09-30 | -$19.02M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | -$13.21M 10-Q/A · filed 2011-09-01 | |
| 2010-12-31 | -$1.68M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |